Skip to content
Tuesday, November 10, 2026
Bingo Systems

The Zimbabwean Government Rejects ‘Unbalanced’ US Healthcare Assistance Deal Due to Information Fears

Medical funding image
The offered American funding would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has turned down a substantial US healthcare agreement valued at $367m (272 million pounds) spanning five years due to Washington's insistence on confidential biological samples.

This rejection came to light following a official document dated December was disclosed, indicating that President Emmerson Mnangagwa believed the agreement was "lopsided".

An official representative later explained that the US was requesting biological samples for research and profit while was unwilling to guarantee the benefits from any future treatments.

"We are forced to start the difficult and regrettable task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has urged further talks to secure a deal suitable to both sides so the nation's critical HIV treatment initiative can proceed.

Wider Background

This development comes after a comparable case in neighbouring Kenya, where a high court halted a similar deal with the US after concerns were raised about the safety of Kenyans' medical information.

After returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

The agency had administered assistance for the US government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to enhance transparency and responsibility.

Based on statements, 16 nations in Africa have so far signed these new health pacts, representing more than $18.3bn in new funding.

Details of the Declined Agreement

This assistance for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this collaboration would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment through American-funded programmes," Tremont said.

However, official spokesman Nick Mangwana maintained the arrangement was "unequal".

"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," he stated.

"Put simply, our country would supply the raw materials for medical research with no certainty that the end products would be available to our people if a new disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining frameworks already set up through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.

"This mechanism is intended to ensure that when a country provides its data, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the capability to create them."

Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.

"We encourage continued dialogue with our US partners on how future collaboration might be arranged in a manner that honours the sovereignty and interests of both nations."

Medical Community Response

Medical experts expressed it acknowledged the government's concerns, but suggested that negotiations must proceed considering much of the nation's HIV programmes relied on foreign aid.

"Where technical issues arise, such as those relating to information security or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," it added.

This impasse highlights the continuing tensions between accepting crucial international aid and protecting national sovereignty in an increasingly data-driven world.

IK
The writer

Isabella King

A gaming industry analyst with over a decade of experience in software development and regulatory compliance for online bingo platforms.

Bingo Systems

Type to search articles.